The association of the IL-1ß-31 polymorphism and the development of neuroinfections

Grażyna Biesiada; Jacek Czepiel; Anna Piątek; Malwina Birczyńska; Justyna Żurańska; Paweł Wołkow; William Perucki; Michał Jędrychowski; Aleskander Garlicki

doi:10.20883/jms.2016.156

Authors

Grażyna Biesiada Jagiellonian University, Department of Infectious and Triopical Diseases
Jacek Czepiel Department of Infectious Diseases, University Hospital in Cracow, Poland
Anna Piątek Department of Infectious Diseases, University Hospital in Cracow, Poland
Malwina Birczyńska Department of Infectious Diseases, University Hospital in Cracow, Poland
Justyna Żurańska Center for Medical Genomics OMICRON, Jagiellonian University Medical College, Krakow, Poland
Paweł Wołkow Center for Medical Genomics OMICRON, Jagiellonian University Medical College, Krakow, Poland
William Perucki Department of Medicine, John Dempsey Hospital, University of Connecticut, Farmington, CT, USA
Michał Jędrychowski Department of Infectious Diseases, University Hospital in Cracow, Poland
Aleskander Garlicki Department of Infectious Diseases, University Hospital in Cracow, Poland

DOI:

https://doi.org/10.20883/jms.2016.156

Keywords:

polymorphisms of genes, neuroinfection, IL-1ß, TNF-?, IL-8

Abstract

Introduction. Inflammation of the meninges can have various clinical courses, from mild, self-limiting in some viral neuroinfections to severe, sometimes ending in death. The pro-inflammatory cascade and defects in the inhibitors of the inflammatory response play an important prognostic role. Single nucleotide polymorphisms (SNPs) of the genes encoding cytokines, influence the severity of the inflammatory response.
Aim. The aim of this study was to evaluate the effect of selected polymorphisms of proinflammatory cytokines IL-1ß, TNF-? and IL-8 on the development of neuroinfections.
Material and Methods. We evaluated the laboratory results of 30 patients treated for bacterial and viral meningitis and compared those to 30 healthy volunteers. The following 4 variants were analyzed for occurrence of genetic polymorphism in patients with meningitis versus the control group: IL-1ß 3953, IL-1ß -31, TNF-? -308, and IL-8 781. Then, we assessed the association between these genetic polymorphisms and the inflammatory response during the course of meningitis.
Results and Conclusions. We observed that polymorphism of the IL-1ß-31 significantly differs between patients and healthy subjects, the IL-1ß -31AA polymorphism existed only in healthy individuals (p < 0.001). The WBC count was dependent on the TNF-? -308 polymorphism with a statistically significant difference (p = 0.021) occurring among persons with variants AA and AG. In conclusion the study showed that the presence of the AA genotype of IL-1ß-31polymorphism may have a protective effect on the development of meningitis. This polymorphism was not observed in any patient with meningitis.

Downloads

Download data is not yet available.

References

Sellner J, Täuber MG, Leib SL. Pathogenesis and pathophysiology of bacterial CNS infections. Handb Clin Neurol. 2010;96:1–16.

van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial meningitis. N Engl J Med. 2010;362:146–154.

Gerber J, Nau R. Mechanisms of injury in bacterial meningitis. Curr Opin Neurol. 2010;23:312–318.

Koedel U, Klein M, Pfister HW. New understandings on the pathophysiology of bacterial meningitis. Curr Opin Infect Dis. 2010;23:217–223.

Hunt WG. Meningitis and encephalitis in adolescents. Adolesc Med State Art Rev. 2010;21:287–317.

Ziai WC, Lewin JJ3rd. Update in the diagnosis and management of central nervous system infections. Neurol Clin. 2008;26:427–468.

Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23:467–492.

Irani DN. Aseptic meningitis and viral myelitis. Neurol Clin. 2008;26:635–655.

Logan SA, MacMahon E. Viral meningitis. BMJ 2008;5:36–40.

Big C, Reineck LA, Aronoff DM. Viral infections of the central nervous system: a case-based review. Clin Med Res. 2009;7:142–146.

Wen AQ, Gu W, Wang J, Feng K, Qin L, Ying C et al. Clinical relevance of IL-1beta promoter polymorphisms (-1470, -511, and -31) in patients with major trauma. Shock. 2010;33:576–582.

Ouma C, Davenport GC, Awandare GA, Keller CC, Were T, Otieno MF et al. Polymorphic variability in the IL-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production. I Infect Dis. 2008;198:1219–1226.

Liu Y, Li S, Zhang G, Nie G, Meng Z, Mao D et al. Genetic variants in IL1A and IL1B contribute to the susceptibility to. 2009 pandemic H1N1influenza A virus. BMC Immunology 2013;14:37.

Moravej A, Rasouli M, Kalani M, Asaei S, Kiany S, Najafipour S et al. IL-1ß (-511T/C) gene polymorphism not IL-1ß (+3953T/C) and LT-? (+252A/G) gene variants confers susceptibility to visceral leishmaniasis. Mol Biol Rep. 2012;39:6907–14.

Omran MH, Ibrahim NE, Youssef SS, Fatouh BE, Nabil W, El-Shami MM et al. Relation of interleukin-1ß gene to treatment response in chronic patients infected with HCV genotype 4. J Infect Dev Ctries 2013;7:851–858.

Sa-Ngasang A, Ohashi J, Naka I, Anantapreecha S, Sawanpanyalert P, Patarapotikul J. Association of IL1B -31C/T and IL1RA variable number of an 86-bp tandem repeat with dengue shock syndrome in Thailand. J Infect Dis. 2014;210:138–145.

Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195–3199.

Fargion S, Valenti L, Dongiovanni P, Fracanzani AL. TNF alpha promoter polymorphisms. Methods Mol Med. 2004;98:47–58.

Titmarsh CJ, Hall S, Tzanakaki G, Kesanopoulos K, Xirogianni A, Scott RJ, et al. Comparison of cytokine gene polymorphisms among Greek patients with invasive meningococcal disease or viral meningitis. J Med Microbiol 2013;62:694–700

Pujhari SK, Ratho RK, Prabhakar S, Mishra B, Modi M. TNF-? promoter polymorphism: a factor contributing to the different immunological and clinical phenotypes in Japanese encephalitis. BMC Infect Dis. 2012;12:23.

Fontes FL, de Araújo LF, Coutinho LG, Leib SL, Agnez-Lima LF. Genetic polymorphisms associated with the inflammatory response in bacterial meningitis. BMC Med Genet. 2015; 16,70. doi: 10.1186/s12881–015–0218–6.

McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-apromoter region associated with susceptibility to cerebral malaria. Nature. 1994;371:508–511.

Cabrera M, Shaw MA, Sharples C, Williams H, Castes M, Convit J et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med. 1995;182:1259–1264.

Song Z, Song Y, Yin J, Shen Y, Yao C, Sun Z et al. Genetic variation in the TNF gene is associated with susceptibility to severe sepsis, but not with mortality. PLoS One. 2012; 7, e46113.

Teuffel O, Ethier MC, Beyene J, Sung L. Association between tumor necrosis factor-promoter -308 A/G polymorphism and susceptibility to sepsis and sepsis mortality: A systematic review and meta-analysis. Crit Care Med. 2010;38:276–282.

Perez AB, Sierra B, Garcia G, Aguirre E, Babel N, Alvarez M et al. Tumor necrosis factor-alpha, transforming growth factor-ß1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever. Hum Immunol. 2010;71:1135–1140

Martinez-Ocana J, Olivo-Diaz A, Salazar-Dominguez T, Reyes-Gordillo J, Tapia-Aquino C, Martínez-Hernández F et al. Plasma cytokine levels and cytokine gene polymorphisms in Mexican patients during the influenza pandemic A(H1N1)pdm09. J Clin Virol. 2013;58:108–113.

Jiang ZD, DuPont HL, Garey K, Price M, Graham G, Okhuysen P et al. A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea. Am J Gastroenterol. 2006;101:1112–1116.

Jiang ZD, Garey KW, Price M, Graham G, Okhuysen P, Dao-Tran T et al. Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile–associated diarrhea. Clin Gastroenterol Hepatol. 2007;5:964–968.

Jiang ZD, Okhuysen PC, Guo DC, He R, King TM, DuPont HL et al. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis. 2003;188:506–511.